Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Before You Order No lot-specific COA available upon request, purity claims without a chromatogram, and pricing significantly below market for the same sequence are the three strongest pre-purchase red flags
The logic is sound
[PMID: 14598827] PubMed record related to this compound for laboratory literature review
Nivolumab versus chemotherapy in patients with advanced melanoma who p rogressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, c ontrolled, open-label, phase 3 trial
US$ 27.89
US$ 23.73
US$ 29.18
US$ 24.20
US$ 20.61
US$ 23.21
US$ 27.18
US$ 25.28
